Development and testing of novel stripixel detectors for the silicon vertex tracker at PHENIX von Haegemann, C., Hoeferkamp, M., Fields, D. E., Zimmerman, A., Turner, J., Malik, M., Edans, L.

Volltext

Bitmap filter: Speeding up exact set similarity joins with bitwise operations von Sandes, Edans F.O., Teodoro, George L.M., Melo, Alba C.M.A.

Volltext

Formalization of Block Pruning: Reducing the Number of Cells Computed in Exact Biological Sequence Comparison Algorithms von Sandes, Edans F O, Teodoro, George L M, Walter, Maria Emilia M T, Martorell, Xavier, Ayguade, Eduard, Melo, Alba C M A

Volltext

MASA‐OpenCL: Parallel pruned comparison of long DNA sequences with OpenCL von Figueiredo, Marco Antonio C., Oliveira Sandes, Edans F., Rodrigues, Genaina N., Teodoro, George L. M., Melo, Alba Cristina M. A.

Volltext

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis von Kappos, Ludwig, Radue, Ernst-Wilhelm, O'Connor, Paul, Polman, Chris, Hohlfeld, Reinhard, Calabresi, Peter, Selmaj, Krzysztof, Agoropoulou, Catherine, Leyk, Malgorzata, Zhang-Auberson, Lixin, Burtin, Pascale

Volltext

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis von O'Connor, Paul, Wolinsky, Jerry S, Confavreux, Christian, Comi, Giancarlo, Kappos, Ludwig, Olsson, Tomas P, Benzerdjeb, Hadj, Truffinet, Philippe, Wang, Lin, Miller, Aaron, Freedman, Mark S

Volltext

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, plac... von Comi, G, Prof, Martinelli, V, MD, Rodegher, M, MD, Moiola, L, MD, Bajenaru, O, Prof, Carra, A, Prof, Elovaara, I, Prof, Fazekas, F, Prof, Hartung, HP, Prof, Hillert, J, Prof, King, J, MD, Komoly, S, Prof, Lubetzki, C, Prof, Montalban, X, Prof, Myhr, KM, Prof, Ravnborg, M, MD, Rieckmann, P, Prof, Wynn, D, MD, Young, C, Prof, Filippi, M, MD

Volltext

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis von Comi, Giancarlo, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Boyko, Alexey, Rocca, Maria A, Filippi, Massimo

Volltext

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial von Kappos, Ludwig, Edan, Gilles, Freedman, Mark S, Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J, Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria

Volltext

Sodium intake and multiple sclerosis activity and progression in BENEFIT von Fitzgerald, Kathryn C., Munger, Kassandra L., Hartung, Hans‐Peter, Freedman, Mark S., Montalbán, Xavier, Edan, Gilles, Wicklein, Eva‐Maria, Radue, Ernst‐Wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto, Strasser‐Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Štourač, P, Talab, R, Zapletalova, O, Kovařova, I, Medova, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun‐Frenay, C, Gout, O, Kallela, M, Pirttila, T, Ruutiainen, J, Koivisto, K, Villringer, A, Altenkirch, H, Wessel, K, Hartung, H‐P, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoffmann, F, Baum, K, Jung, S, Petereit, H, Reske, D, Sailer, M, Kohler, J, Sommer, N, Hohlfeld, R, Gold, R, Rieckmann, P, Komoly, R, Jakab, G, Csiba, L, Vecsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Cosi, V, Anten, B, Myhr, K‐M, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega‐Jazbec, S, Montalban, X, Arbizu, T, Saiz, A, Barcena, J, Arroyo, R, Fernandez, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, Riordan, J O, Howell, S

Volltext

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis von Giovannoni, Gavin, Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Sørensen, Per Soelberg, Vermersch, Patrick, Chang, Peter, Hamlett, Anthony, Musch, Bruno, Greenberg, Steven J

Volltext

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study von OʼConnor, Paul, Comi, Giancarlo, Freedman, Mark S, Miller, Aaron E, Kappos, Ludwig, Bouchard, Jean-Pierre, Lebrun-Frenay, Christine, Mares, Jan, Benamor, Myriam, Thangavelu, Karthinathan, Liang, Jinjun, Truffinet, Philippe, Lawson, Victoria J, Wolinsky, Jerry S

Volltext

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients von Balloy, G., Pelletier, J., Suchet, L., Lebrun, C., Cohen, M., Vermersch, P., Zephir, H., Duhin, E., Gout, O., Deschamps, R., Le Page, E., Edan, G., Labauge, P., Carra-Dallieres, C., Rumbach, L., Berger, E., Lejeune, P., Devos, P., N’Kendjuo, J.-B., Coustans, M., Auffray-Calvier, E., Daumas-Duport, B., Michel, L., Lefrere, F., Laplaud, D. A., Brosset, C., Derkinderen, P., de Seze, J., Wiertlewski, S.

Volltext

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score von De Jager, Philip L, MD, Chibnik, Lori B, PhD, Cui, Jing, PhD, Reischl, Joachim, PhD, Lehr, Stephan, PhD, Simon, K Claire, PhD, Aubin, Cristin, BS, Bauer, David, PhD, Heubach, Jürgen F, MD, Sandbrink, Rupert, MD, Tyblova, Michaela, MD, Lelkova, Petra, MD, Havrdova, Eva, MD, Pohl, Christoph, MD, Horakova, Dana, MD, Ascherio, Alberto, MD, Hafler, David A, MD, Karlson, Elizabeth W, MD

Volltext

Aggressive multiple sclerosis (1): Towards a definition of the phenotype von Iacobaeus, Ellen, Arrambide, Georgina, Amato, Maria Pia, Derfuss, Tobias, Vukusic, Sandra, Hemmer, Bernhard, Tintore, Mar, Brundin, Lou, Berger, Joseph, Boyko, Alexey, Brinar, Vesna, Brownlee, Wallace, Ciccarelli, Olga, Coles, Alasdair, Correale, Jorge, Cutter, Gary, Edan, Gilles, Evangelou, Nikolaos, Fernandez, Oscar, Frederiksen, Jette, Gold, Ralf, Hacohen, Yael, Hartung, Hans-Peter, Hellwig, Kerstin, Hillert, Jan, Imitola, Jaime, Kalincik, Tomas, Kappos, Ludwig, Khoury, Samia, Kim, Ho Jin, Havrdová, Eva Kubala, Liblau, Roland, Lycke, Jan, Montalban, Xavier, Muraro, Paolo, Reingold, Stephen, Schmierer, Klaus, Sellebjerg, Finn, Sørensen, Per Soelberg, Solari, Alessandra, Sormani, Maria Pia, Thompson, Alan, Trapp, Bruce, Tremlett, Helen, Trojano, Maria, Tur, Carmen, Uccelli, Antonio, van Pesch, Vincent, Waubant, Emmanuelle

Volltext

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT... von Kappos, Ludwig, MD, Freedman, Mark S, MD, Polman, Chris H, MD, Edan, Gilles, MD, Hartung, Hans-Peter, MD, Miller, David H, MD, Montalbán, Xavier, MD, Barkhof, Frederik, MD, Radü, Ernst-Wilhelm, MD, Metzig, Carola, MD, Bauer, Lars, MD, Lanius, Vivian, PhD, Sandbrink, Rupert, MD, Pohl, Christoph, MD

Volltext

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage von Filippi, Massimo, Rocca, Maria A, Pagani, Elisabetta, De Stefano, Nicola, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Boyko, Alexei N, Comi, Giancarlo

Volltext

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study von Devonshire, Virginia, MD, Havrdova, Eva, MD, Radue, Ernst Wilhelm, Prof, O'Connor, Paul, MD, Zhang-Auberson, Lixin, MD, Agoropoulou, Catherine, PhD, Häring, Dieter Adrian, PhD, Francis, Gordon, MD, Kappos, Ludwig, Prof

Volltext

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta von Wynn, Daniel, MD, Kaufman, Michael, MD, Montalban, Xavier, MD, Vollmer, Timothy, MD, Simon, Jack, MD, Elkins, Jacob, MD, O'Neill, Gilmore, MD, Neyer, Lauri, PhD, Sheridan, James, PhD, Wang, Chungchi, PhD, Fong, Alice, PharmD, Rose, John W, MD

Volltext

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD... von Mikol, Daniel D, MD, Barkhof, Frederik, MD, Chang, Peter, PhD, Coyle, Patricia K, MD, Jeffery, Douglas R, MD, Schwid, Steven R, MD, Stubinski, Bettina, MD, Uitdehaag, Bernard MJ, MD

Volltext